A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure

Atherosclerosis, myocardial infarction (MI) and heart failure (HF) are the main causes of mortality and morbidity around the globe. New therapies are needed to better manage ischemic heart disease and HF as existing strategies are not curative. Resveratrol is a stilbene polyphenolic compound with fa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pema Raj, Sijo Joseph Thandapilly, Jeffrey Wigle, Shelley Zieroth, Thomas Netticadan
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/407e793447334e0db2b1de53351ea51b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:407e793447334e0db2b1de53351ea51b
record_format dspace
spelling oai:doaj.org-article:407e793447334e0db2b1de53351ea51b2021-11-11T18:34:27ZA Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure10.3390/molecules262166001420-3049https://doaj.org/article/407e793447334e0db2b1de53351ea51b2021-10-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6600https://doaj.org/toc/1420-3049Atherosclerosis, myocardial infarction (MI) and heart failure (HF) are the main causes of mortality and morbidity around the globe. New therapies are needed to better manage ischemic heart disease and HF as existing strategies are not curative. Resveratrol is a stilbene polyphenolic compound with favorable biological effects that counter chronic diseases. Current evidence suggests that resveratrol is cardioprotective in animal models of atherosclerosis, ischemic heart disease, and HF. Though clinical studies for resveratrol have been promising, evidence remains inadequate to introduce it to the clinical setting. In this narrative review, we have comprehensively discussed the relevant compelling evidence regarding the efficacy of resveratrol as a new therapeutic agent for the management of atherosclerosis, MI and HF.Pema RajSijo Joseph ThandapillyJeffrey WigleShelley ZierothThomas NetticadanMDPI AGarticleresveratrolatherosclerosismyocardial infarctionheart failureOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6600, p 6600 (2021)
institution DOAJ
collection DOAJ
language EN
topic resveratrol
atherosclerosis
myocardial infarction
heart failure
Organic chemistry
QD241-441
spellingShingle resveratrol
atherosclerosis
myocardial infarction
heart failure
Organic chemistry
QD241-441
Pema Raj
Sijo Joseph Thandapilly
Jeffrey Wigle
Shelley Zieroth
Thomas Netticadan
A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
description Atherosclerosis, myocardial infarction (MI) and heart failure (HF) are the main causes of mortality and morbidity around the globe. New therapies are needed to better manage ischemic heart disease and HF as existing strategies are not curative. Resveratrol is a stilbene polyphenolic compound with favorable biological effects that counter chronic diseases. Current evidence suggests that resveratrol is cardioprotective in animal models of atherosclerosis, ischemic heart disease, and HF. Though clinical studies for resveratrol have been promising, evidence remains inadequate to introduce it to the clinical setting. In this narrative review, we have comprehensively discussed the relevant compelling evidence regarding the efficacy of resveratrol as a new therapeutic agent for the management of atherosclerosis, MI and HF.
format article
author Pema Raj
Sijo Joseph Thandapilly
Jeffrey Wigle
Shelley Zieroth
Thomas Netticadan
author_facet Pema Raj
Sijo Joseph Thandapilly
Jeffrey Wigle
Shelley Zieroth
Thomas Netticadan
author_sort Pema Raj
title A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
title_short A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
title_full A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
title_fullStr A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
title_full_unstemmed A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
title_sort comprehensive analysis of the efficacy of resveratrol in atherosclerotic cardiovascular disease, myocardial infarction and heart failure
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/407e793447334e0db2b1de53351ea51b
work_keys_str_mv AT pemaraj acomprehensiveanalysisoftheefficacyofresveratrolinatheroscleroticcardiovasculardiseasemyocardialinfarctionandheartfailure
AT sijojosephthandapilly acomprehensiveanalysisoftheefficacyofresveratrolinatheroscleroticcardiovasculardiseasemyocardialinfarctionandheartfailure
AT jeffreywigle acomprehensiveanalysisoftheefficacyofresveratrolinatheroscleroticcardiovasculardiseasemyocardialinfarctionandheartfailure
AT shelleyzieroth acomprehensiveanalysisoftheefficacyofresveratrolinatheroscleroticcardiovasculardiseasemyocardialinfarctionandheartfailure
AT thomasnetticadan acomprehensiveanalysisoftheefficacyofresveratrolinatheroscleroticcardiovasculardiseasemyocardialinfarctionandheartfailure
AT pemaraj comprehensiveanalysisoftheefficacyofresveratrolinatheroscleroticcardiovasculardiseasemyocardialinfarctionandheartfailure
AT sijojosephthandapilly comprehensiveanalysisoftheefficacyofresveratrolinatheroscleroticcardiovasculardiseasemyocardialinfarctionandheartfailure
AT jeffreywigle comprehensiveanalysisoftheefficacyofresveratrolinatheroscleroticcardiovasculardiseasemyocardialinfarctionandheartfailure
AT shelleyzieroth comprehensiveanalysisoftheefficacyofresveratrolinatheroscleroticcardiovasculardiseasemyocardialinfarctionandheartfailure
AT thomasnetticadan comprehensiveanalysisoftheefficacyofresveratrolinatheroscleroticcardiovasculardiseasemyocardialinfarctionandheartfailure
_version_ 1718431756943622144